Variant report
Variant | nsv976730 |
---|---|
Chromosome Location | chr12:26082055-26086201 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:26083077..26084676-chr12:26111179..26112864,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000123094 | chromatin interactions |
ENSG00000246695 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191669247 | chr12:26082064-26082065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34378553 | chr12:26082079-26082080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536237258 | chr12:26082098-26082099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74941990 | chr12:26082124-26082125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569992419 | chr12:26082163-26082164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182186013 | chr12:26082176-26082177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186344845 | chr12:26082247-26082248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577325888 | chr12:26082278-26082279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145346726 | chr12:26082362-26082363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190947156 | chr12:26082408-26082409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572109119 | chr12:26082455-26082456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113556467 | chr12:26082491-26082492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560842479 | chr12:26082508-26082509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576424100 | chr12:26082514-26082515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs207472759 | chr12:26082519-26082520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543663158 | chr12:26082523-26082524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564937046 | chr12:26082529-26082530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145221632 | chr12:26082532-26082533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547616789 | chr12:26082542-26082543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12423046 | chr12:26082580-26082581 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs530065265 | chr12:26082604-26082605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553963156 | chr12:26082614-26082615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148792305 | chr12:26082633-26082634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569680918 | chr12:26082697-26082698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537353542 | chr12:26082750-26082751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79783578 | chr12:26082760-26082761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1691895 | chr12:26082762-26082763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1797972 | chr12:26082801-26082802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114023278 | chr12:26082802-26082803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151292478 | chr12:26082804-26082805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76875509 | chr12:26082818-26082819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577594250 | chr12:26082830-26082831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1691890 | chr12:26082858-26082859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536321534 | chr12:26082863-26082864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554616507 | chr12:26082875-26082876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1691887 | chr12:26082888-26082889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376378916 | chr12:26082916-26082917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2643929 | chr12:26082921-26082922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371446917 | chr12:26082922-26082923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78159630 | chr12:26082944-26082945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74793574 | chr12:26082988-26082989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543400937 | chr12:26083026-26083027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1797973 | chr12:26083038-26083039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570319934 | chr12:26083062-26083063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533722087 | chr12:26083065-26083066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565177671 | chr12:26083087-26083088 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs115384077 | chr12:26083109-26083110 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs201187645 | chr12:26083120-26083121 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs79819871 | chr12:26083187-26083188 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs182415551 | chr12:26083207-26083208 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 17133270 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 22048815 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Heart disease | 21282601 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Gastric cancer | 24379144 | CNVD |
Gastric cancer | 19545448 | CNVD |
Lung cancer | 20031968 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung adenocarcinoma | 19826477 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19826477 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Lung cancer | 19671679 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 21569311 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:26079600-26082800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr12:26081400-26082800 | Enhancers | NHDF-Ad | bronchial |
3 | chr12:26081600-26082400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr12:26081600-26082600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr12:26081600-26082800 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr12:26081600-26082800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr12:26081600-26082800 | Enhancers | Hela-S3 | cervix |
8 | chr12:26081600-26082800 | Enhancers | Osteobl | bone |
9 | chr12:26081600-26083000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr12:26081800-26082400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr12:26081800-26082400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr12:26081800-26082600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr12:26081800-26082600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr12:26081800-26082600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr12:26081800-26082600 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr12:26082000-26082200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr12:26082200-26082600 | Enhancers | Brain Substantia Nigra | brain |
18 | chr12:26082400-26082800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
19 | chr12:26082600-26082800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr12:26082800-26086200 | Weak transcription | NHDF-Ad | bronchial |
21 | chr12:26082800-26086400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr12:26085400-26110600 | Weak transcription | Aorta | Aorta |
23 | chr12:26086200-26086800 | Enhancers | NHDF-Ad | bronchial |